DEFA14A: Collegium Pharmaceutical Sets Date for 2025 Annual Shareholder Meeting

Collegium Pharmaceutical will hold its annual shareholder meeting virtually on May 15, 2025, to vote on director elections, executive compensation, and other proposals.

Summary

• Collegium Pharmaceutical, Inc. will hold its annual shareholder meeting on May 15, 2025, virtually via live webcast at 8:30 a.m. Eastern Time.
• Shareholders will vote on several proposals, including the election of eight directors.
• They will also vote on the advisory approval of executive compensation and the preferred frequency of shareholder advisory votes on executive compensation.
• The ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, is also on the agenda.
• Finally, shareholders will vote to approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan.
• Shareholders are encouraged to access and review the proxy materials online at www.envisionreports.com/COLL.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral but necessary corporate process. The information is presented clearly and accessibly, contributing to a slightly positive sentiment.

Positives

• The company is providing easy online access to proxy materials for shareholders.
• Shareholders have the option to receive future materials electronically, which is environmentally friendly.

Future Outlook

The document outlines the agenda for the upcoming shareholder meeting and provides information on how shareholders can participate and vote.

Industry Context

This is a standard proxy statement outlining the business to be conducted at the annual shareholder meeting, a routine part of corporate governance.

Stakeholder Impact

• Shareholders are directly impacted by the proposals being voted on.
• The outcome of the votes will influence the company's governance and direction.

Next Steps

• Shareholders should review the proxy materials.
• Shareholders should vote on the proposals either online or by requesting a paper copy of the proxy materials.
• Attend the virtual annual meeting on May 15, 2025.

Key Dates

Keywords

shareholder meeting, proxy statement, directors, executive compensation, equity incentive plan, Deloitte & Touche, voting, Collegium Pharmaceutical